Human medicines European public assessment report (EPAR): Wilzin, zinc, Date of authorisation: 12/10/2004, Revision: 12, Status: Authorised

Innovation Task Force (ITF) briefing meeting request form

UPD refresher webinar for marketing authorisation holders on volume of sales submission, Online, from 5 December 2024, 10:00 (CET) to 5 December 2024, 11:00 (CET)

Minutes of the CHMP meeting 22-25 July 2024

ICH Q4B Evaluation and recommendation of pharmacopoeial texts for use in the ICH regions - Scientific guideline

ICH Q4B(R1) Guideline on evaluation and recommendation of pharmacopoeial texts for use in the ICH regions - Step 5

Frequently asked questions about parallel distribution

Human medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: Authorised

HMA / EMA Task Force on the Availability of Authorised Medicines for Human and Veterinary Use (2016-2024)

Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group